Neoinnervation and neovascularization of acellular pericardial-derived scaffolds in myocardial infarcts

Engineered bioimplants for cardiac repair require functional vascularization and innervation for proper integration with the surrounding myocardium. The aim of this work was to study nerve sprouting and neovascularization in an acellular pericardial-derived scaffold used as a myocardial bioimplant. To this end, 17 swine were submitted to a myocardial infarction followed by implantation of a decellularized human pericardial-derived scaffold. After 30 days, animals were sacrificed and hearts were analyzed with hematoxylin/eosin and Masson’s and Gallego’s modified trichrome staining. Immunohistochemistry was carried out to detect nerve fibers within the cardiac bioimplant by using βIII tubulin and S100 labeling. Isolectin B4, smooth muscle actin, CD31, von Willebrand factor, cardiac troponin I, and elastin antibodies were used to study scaffold vascularization. Transmission electron microscopy was performed to confirm the presence of vascular and nervous ultrastructures. Left ventricular ejection fraction (LVEF), cardiac output (CO), stroke volume, end-diastolic volume, end-systolic volume, end-diastolic wall mass, and infarct size were assessed by using magnetic resonance imaging (MRI). Newly formed nerve fibers composed of several amyelinated axons as the afferent nerve endings of the heart were identified by immunohistochemistry. Additionally, neovessel formation occurred spontaneously as small and large isolectin B4-positive blood vessels within the scaffold. In summary, this study demonstrates for the first time the neoformation of vessels and nerves in cell-free cardiac scaffolds applied over infarcted tissue. Moreover, MRI analysis showed a significant improvement in LVEF (P = 0.03) and CO (P = 0.01) and a 43 % decrease in infarct size (P = 0.007).

[1]  C. Dumontet,et al.  Tubulin targets in the pathobiology and therapy of glioblastoma multiforme. I. class III β‐tubulin , 2009, Journal of cellular physiology.

[2]  L. Williams,et al.  Preparation of acellular myocardial scaffolds with well-preserved cardiomyocyte lacunae, and method for applying mechanical and electrical simulation to tissue construct. , 2014, Methods in molecular biology.

[3]  Xiaohong Sun,et al.  Differentiation of neural stem cells into Schwann-like cells in vitro. , 2010, Biochemical and biophysical research communications.

[4]  Eduarda Dráberová,et al.  Tubulin targets in the pathobiology and therapy of glioblastoma multiforme. II. γ‐tubulin , 2009, Journal of cellular physiology.

[5]  E. W. van Stee Autonomic innervation of the heart. , 1978, Environmental health perspectives.

[6]  P. Most,et al.  S100A1: A Multifaceted Therapeutic Target in Cardiovascular Disease , 2010, Journal of cardiovascular translational research.

[7]  Tatsuya Shimizu,et al.  Sympathetic Innervation Induced in Engrafted Engineered Cardiomyocyte Sheets by Glial Cell Line Derived Neurotrophic Factor In Vivo , 2013, BioMed research international.

[8]  E. W. V. Stee Autonomic innervation of the heart. , 1978 .

[9]  C. Bouten,et al.  Combining tissue repair and tissue engineering; bioactivating implantable cell-free vascular scaffolds , 2014, Heart.

[10]  A. Leite-Moreira,et al.  S100A1: a major player in cardiovascular performance. , 2014, Physiological research.

[11]  M. Bernaudin,et al.  Hypoxia‐inducible factor‐2α (HIF‐2α), but not HIF‐1α, is essential for hypoxic induction of class III β‐tubulin expression in human glioblastoma cells , 2014, The FEBS journal.

[12]  D. Ingber Mechanical signaling and the cellular response to extracellular matrix in angiogenesis and cardiovascular physiology. , 2002, Circulation research.

[13]  B. Sanchez,et al.  Online monitoring of myocardial bioprosthesis for cardiac repair. , 2014, International journal of cardiology.

[14]  Jennifer M. Singelyn,et al.  Injectable Materials for the Treatment of Myocardial Infarction and Heart Failure: The Promise of Decellularized Matrices , 2010, Journal of cardiovascular translational research.

[15]  A. Bayés-Genís,et al.  Ingenierı́a tisular cardiaca y corazón bioartificial , 2018 .

[16]  H. Aly,et al.  Viability and neural differentiation of mesenchymal stem cells derived from the umbilical cord following perinatal asphyxia , 2012, Journal of Perinatology.

[17]  A. Remppis,et al.  S100A1 gene transfer: a strategy to strengthen engineered cardiac grafts , 2004, The journal of gene medicine.

[18]  A. Bayés‐Genís,et al.  One hundred years of myocardial infarction. , 2012, European heart journal.

[19]  Claus W Heizmann,et al.  S100 proteins: structure, functions and pathology. , 2002, Frontiers in bioscience : a journal and virtual library.

[20]  Milica Radisic,et al.  Biomaterials in myocardial tissue engineering , 2016, Journal of tissue engineering and regenerative medicine.

[21]  L. V. Williams,et al.  Tissue repair and the dynamics of the extracellular matrix. , 2004, The international journal of biochemistry & cell biology.

[22]  Gordana Vunjak-Novakovic,et al.  Bioengineering heart muscle: a paradigm for regenerative medicine. , 2011, Annual review of biomedical engineering.